References
- Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
- Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1–205.11.
- Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57:1042–1049.
- Lau TK, Chen F, Pan X, Pooh RK, Jiang F, Li Y, Jiang H, et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 2012;25:1370–1374.
- Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913–920.
- Chen EZ, Chiu RW, Sun H, Akolekar R, Chan KC, Leung TY, Jiang P, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS ONE 2011;6:e21791.
- Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14:296–305.
- Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119:890–901.
- Lau TK, Chan MK, Salome Lo PS, Connie Chan HY, Kim Chan WS, Koo TY, Joyce Ng HY, Pooh RK. Clinical utility of noninvasive fetal trisomy (NIFTY) test – early experience. J Matern Fetal Neonatal Med. 2012 Apr 28. [Epub ahead of print].
- Wertz DC, Fletcher JC, Berg K. Review of Ethical Issues in Medical Genetics. Report of Consultants to WHO. World Health Organization Human Genetics Programme. 2003. p. 73
- Balkan M, Kalkanli S, Akbas H, Yalinkaya A, Alp MN, Budak T. Parental decisions regarding a prenatally detected fetal chromosomal abnormality and the impact of genetic counseling: an analysis of 38 cases with aneuploidy in Southeast Turkey. J Genet Couns 2010;19:241–246.
- Hamamy HA, Dahoun S. Parental decisions following the prenatal diagnosis of sex chromosome abnormalities. Eur J Obstet Gynecol Reprod Biol 2004;116:58–62.
- Holmes-Siedle M, Ryynanen M, Lindenbaum RH. Parental decisions regarding termination of pregnancy following prenatal detection of sex chromosome abnormality. Prenat Diagn 1987;7:239–244.
- Chan LW, Chau MC, Leung TY, Fung TY, Leung TN, Lau TK. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population. Prenat Diagn 2005;25:1248–1252.
- Jeon KC, Chen LS, Goodson P. Decision to abort after a prenatal diagnosis of sex chromosome abnormality: a systematic review of the literature. Genet Med 2012;14:27–38.
- Susman MR, Amor DJ, Muggli E, Jaques AM, Halliday J. Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome. Genet Med 2010;12:298–303.
- Peters D, Chu T, Yatsenko SA, Hendrix N, Hogge WA, Surti U, Bunce K, et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011;365:1847–1848.